Report: EMA Approval Recommendations Rose in 2015, Cancer Drugs Doubled
The European Medicines Agency recommendations for drug approvals saw a steady uptick in 2015, even as the number of new active substances fell slightly.
Source: International Pharmaceutical Regulatory Monitor